According to the data presented, combination treatment of RZ-001 with atezolizumab and bevacizumab demonstrated an objective response rate (ORR) of 38.5% (confirmed) and 46.2% (unconfirmed) based on ...
With Helio Liver, patients can have the blood test done right in the office, which is much more convenient. This convenience ...
Can training your brain's reward circuits strengthen your immune response to vaccination? A new randomised controlled trial ...
A new update from the American Gastroenterological Association (AGA) urges stronger prevention efforts and better ...
A new study published in The Journal of Immunology by researchers at the Josep Carreras Leukaemia Research Institute (IJC) ...
Recent Updates in Basic Research, Drug Discovery and Treatment - Volume II", we are pleased to announce the launch ...
A major study presented today at ESCMID Global 2026 has found that antiretroviral therapy (ART) reduces accelerated ...
A phase 2 study evaluates the safety and efficacy of brentuximab vedotin and nivolumab plus chemotherapy in patients with early-stage classical Hodgkin lymphoma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results